Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

50 results about "Quantum annealing" patented technology

Quantum annealing (QA) is a metaheuristic for finding the global minimum of a given objective function over a given set of candidate solutions (candidate states), by a process using quantum fluctuations. Quantum annealing is used mainly for problems where the search space is discrete (combinatorial optimization problems) with many local minima; such as finding the ground state of a spin glass. It was formulated in its present form by T. Kadowaki and H. Nishimori (ja) in "Quantum annealing in the transverse Ising model" though a proposal in a different form had been made by A. B. Finnila, M. A. Gomez, C. Sebenik and J. D. Doll, in "Quantum annealing: A new method for minimizing multidimensional functions".

Parameter inversion method of probability integral method based on quantum annealing method

The present invention relates to a parameter inversion method of a probability integral method based on a quantum annealing method. The method comprises: giving an initial value B0 of a parameter of the probability integral, and determining a temperature and transverse field variation function, a fluctuation range +/-[delta]B of each parameter of the probability integral, the maximum allowable step length scale of the parameter, and the number of times M of internal loops; by calculating the objective function under the gradually decreased temperature and transverse field, determining an optimal parameter solution at each temperature; and finally outputting the optimal parameter solution by determining the accuracy requirement or whether the minimum temperature and the transverse field arereached. According to the method disclosed by the present invention, based on inheriting the advantages of the simulated annealing method, the thermal fluctuation mechanism of the simulated annealingmethod is replaced by the quantum fluctuation mechanism, so that the shortcomings of the simulated annealing algorithm are effectively overcome; and compared with the parameter inversion method of the probability integral based on the simulated annealing, by using the method disclosed by the present invention, the convergence speed and the possibility of jumping out of the local optimal solutionare effectively improved, the global optimization ability is enhanced, and the parameter inversion of the probability integral can be more accurate and reliable.
Owner:ANHUI UNIV OF SCI & TECH

Parallel quantum annealing target point distribution calculation method

The invention discloses a parallel quantum annealing target point distribution calculation method which comprises the steps of establishing a tumor target area and damaged organ data model through CT or MR data image analysis and doctor diagnosis; then, performing quick calculation of key point dosage distribution through a Gamma ray three-dimensional orientation rotating focusing radiotherapy machine beam characteristic, comparing the key point dosage distribution with a clinically required radiotherapy target, defining a target function according to a prescription dosage of the target area and the tolerable dosage of the damaged organ, setting a choice rule according to a simulated annealing algorithm, and performing new calculation comparison, and finally obtaining an anticipated result; and finally, performing accurate calculation on dosage distribution according to the parameter which corresponds with the calculated anticipated result, and obtaining final dosage distribution in the irradiation area. According to the parallel quantum annealing target point distribution calculation method, automatic machine calculation is utilized in a calculation process, thereby reducing subjective factors such as physicist experience, realizing no requirement for calculation process intervention by a plan designer, and realizing relatively objective calculation result. Furthermore, reversed plan designing realizes advantages of reducing subjective factors such as physicist experience, increasing plan designing speed, improving economic benefit and social benefit of radiotherapy, and realizing better satisfaction for a clinical requirement.
Owner:西安一体医疗科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products